Thu, Dec 18, 2014, 5:53 AM EST - U.S. Markets open in 3 hrs 37 mins

Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

believe220000 2 posts  |  Last Activity: Dec 15, 2014 8:04 AM Member since: May 10, 2010
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • believe220000 by believe220000 Dec 15, 2014 8:04 AM Flag

    Insmed Appoints Myrtle Potter to its Board of DirectorsPharmaceutical executive brings 30 years of commercial and operations leadership
    BUSINESS WIRE 8:00 AM ET 12/15/2014
    BRIDGEWATER, N.J.--(BUSINESS WIRE)--

    Insmed Incorporated (INSM) today announced the appointment of Myrtle Potter to its Board of Directors. Ms. Potter is currently CEO of Myrtle Potter & Company, a life sciences and healthcare advisory firm she founded in 2005. She was previously the President of Commercial Operations and Chief Operating Officer of Genentech and had extensive experience in senior operating roles at Bristol-Myers Squibb and Merck.

    “It is with great pleasure that we welcome Myrtle to our Board. Her considerable industry experience, deep insight into successful commercialization strategies and experience leading pharmaceutical companies in bringing new therapies to market will be extremely valuable to Insmed(INSM) as we prepare for the commercialization of ARIKAYCETM,” stated Don Hayden, Jr., Chairman of the Board of Insmed(INSM).

    In accepting this appointment, Ms. Potter stated, “I am excited to join Insmed(INSM) at this important stage in its development. I believe ARIKAYCE has the potential to have a positive impact on patients’ lives and I believe Insmed(INSM) has the potential to continue to develop new treatments for patients with serious rare diseases. I look forward to working with my fellow Insmed Board members and the management team to help the Company achieve its strategic objectives.”

    Ms. Potter serves as a Director of Liberty Mutual Holding Company, Rite Aid, Everyday Health and Proteus Digital Health, and as a Trustee of The University of Chicago. She served on the Board of Medco Health Solutions from December 2007 until its acquisition by Express Scripts in April 2012, and continued as a Director of Express Scripts until June 2012.

    From 2000 to 2005 Ms. Potter was Preside

  • believe220000 by believe220000 Dec 15, 2014 7:14 AM Flag

    Insmed: Approval Of Pediatric Investigation Plan By EMA's Pediatric Committee Expected In 1Q 2015 INSM
    DOW JONES & COMPANY, INC. 7:06 AM ET 12/15/2014

    Insmed: Approval Of Pediatric Investigation Plan By EMA's Pediatric Committee Expected In 1Q 2015 INSM
    DOW JONES & COMPANY, INC. 7:06 AM ET 12/15/2014

    Insmed: Approval Of Pediatric Investigation Plan By EMA's Pediatric Committee Expected In 1Q 2015 INSM
    DOW JONES & COMPANY, INC. 7:06 AM ET 12/15/2014
    Insmed: Approval Of Pediatric Investigation Plan By EMA's Pediatric Committee Expected In 1Q 2015 INSM

INSM
14.37+0.67(+4.89%)Dec 17 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.